We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




ESC to Acquire Coherent Medical Group

By HospiMedica staff writers
Posted on 08 Mar 2001
ESC Medical Systems Ltd. More...
(Yokneam, Israel) has agreed to acquire Coherent Medical Group (CMG, Santa Clara, CA, USA), a division of Coherent, Inc. for a total of about US$203 million in cash, notes, and stock. The move quickly followed an earlier announcement that the two parties were having discussions about a possible transaction.

Following the closing of the transaction, ESC plans to change its name to Lumenis, derived from lumen, the Latin word for light. Bernard Couillaud, president and CEO of Coherent, Inc. will be appointed to ESC's board of directors. Coherent will continue to supply parts and components and provide on a transitional basis ongoing operational support. ESC manufactures medical devices utilizing intense pulsed light source and laser technology for aesthetic, surgical, and other medical applications. Coherent also manufactures medical lasers. Combined sales for the two businesses in the year 2000 were around $360 million.

"We are excited about the opportunities that this transaction will create for our customers, shareholders, and employees,” said Yacha Sutton, president and CEO of ESC. "CMG's products and distribution assets are highly complementary to ESC.”

Dr. Couillaud commented, "The transaction furthers Coherent's strategic objectives by giving us the opportunity to concentrate on the significant opportunities that we have in our telecommunications, semiconductor, and electro-optics markets.”
ESC Medical Systems Ltd. (Yokneam, Israel; www.escmed.com) has agreed to acquire Coherent Medical Group (CMG, Santa Clara, CA, USA; www.coherentinc.com), a division of Coherent, Inc. for a total of about US$203 million in cash, notes, and stock. The move quickly followed an earlier announcement that the two parties were having discussions about a possible transaction.

Following the closing of the transaction, ESC plans to change its name to Lumenis, derived from lumen, the Latin word for light. Bernard Couillaud, president and CEO of Coherent, Inc. will be appointed to ESC's board of directors. Coherent will continue to supply parts and components and provide on a transitional basis ongoing operational support. ESC manufactures medical devices utilizing intense pulsed light source and laser technology for aesthetic, surgical, and other medical applications. Coherent also manufactures medical lasers. Combined sales for the two businesses in the year 2000 were around $360 million.

"We are excited about the opportunities that this transaction will create for our customers, shareholders, and employees,” said Yacha Sutton, president and CEO of ESC. "CMG's products and distribution assets are highly complementary to ESC.”

Dr. Couillaud commented, "The transaction furthers Coherent's strategic objectives by giving us the opportunity to concentrate on the significant opportunities that we have in our telecommunications, semiconductor, and electro-optics markets.”



Related Links:
ESC
Coherent

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.